JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaramillo, J.
Right arrow Articles by Volle, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaramillo, J.
Right arrow Articles by Volle, R. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 158, Issue 1, 80-88, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


GANGLION BLOCKADE BY MUSCARINE, OXOTREMORINE AND AHR-602

Jorge Jaramillo 1 and Robert L. Volle 1

1 Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana

Muscarine and oxotremorine caused postganglionic firing that was blocked by atropine. The surface potential evoked by muscarine and oxotremorine was biphasic and consisted of hyperpolarization followed by depolarization. Blockade of transmission by the drugs occurred during hyperpolarization and was characterized by an increase in the negative afterpotential. The synaptic potential was depressed by muscarine and oxotremorine. The relationship between drug-induced hyperpolarization and ganglion blockade was questioned. Oxotremorine caused a persistent depolarization of the ganglion (several hours). The actions of muscarine and oxotremorine are qualitatively similar to those of methacholine. N-benzyl-3-pyrrolidyl acetate methobromide (AHR-602) caused atropine-sensitive ganglionic firing and a monophasic surface depolarization that was unaffected by atropine. Ganglionic blockade by AHR-602 occurred during the depolarization, was unaffected by atropine, was antagonized by tetanic stimulation and was independent of frequency of preganglionic stimulation. The blocking actions of AHR-602 are similar to those of 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride. It is unlikely that the block of transmission by AHR-602 was related to ganglionic depolarization.

Submitted on April 10, 1967
Accepted on May 31, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.